• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » MHRA may allow drug reaction reporting through social media

MHRA may allow drug reaction reporting through social media

September 13, 2011
CenterWatch Staff

Drug reaction reporting from smartphones, Facebook and Twitter is being considered after the success of a scheme allowing direct reporting from GP practice IT systems, according to GP Online.

The MHRA is now “actively working on introducing other ways of reporting to make it easier and encourage more reporting.”

Mick Foy, group manager for vigilance and risk management of medicines at the MHRA, said, “Applications for smartphones, improved web reporting forms and the use of social media such as Twitter and Facebook are being carefully considered as potential routes for reporting.”

Valid reports have to contain information on the drug, reaction, patient and reporter, and allow the agency to follow-up reports, he continued.

“It is important to consider the structure of the information for inclusion on our database, something Twitter and Facebook do not easily lend themselves to,” said Foy.

Plans to expand submission of yellow cards follow the agency’s launch of direct reporting from practice IT systems in order to increase reports from GPs.

The 1,100 GP practices using the SystmOne IT system can use a yellow card reporting feature that interacts directly with the MHRA database.

Foy said the MHRA had now received 1,008 yellow cards direct from practice IT systems and expected to receive another 500 by the end of 2011.

“In 2010, a total of 2,237 yellow cards were received directly from GPs by all reporting methods,” he said. “An additional 1,500 yellow cards from SystmOne will mean more than a 60% annual increase.”

Foy said the MHRA was now in discussions with the government IT agency NHS Connecting for Health and individual GP IT system providers about introducing electronic yellow card reporting into other GP systems.

Upcoming Events

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing